Exercise of Warrants and Total Voting Rights

RNS Number : 7889P
S-Ventures PLC
14 February 2023

S-VENTURES PLC

(“S-Ventures” or the “Company”)

Exercise of Warrants and Total Voting Rights

S-Ventures plc (AQSE: SVEN) (OTCQB: SVTPF), the enterprise company investing in and growing exciting brands across the natural, wellness and food-tech categories, is pleased to announce that it has received notifications from warrantholder to exercise a total of 243,900 warrants, of which 237,800 warrants were exercised at 2 pence per warrant and 6,100 warrants were exercised at 4 pence per warrant, raising a total of £5,000.00 for the Company.

 

Admission 

 

Application has been made for the 243,900 new ordinary shares, which will rank pari passu with the existing ordinary shares in issue, to be admitted to trading on the Aquis Stock Exchange Growth Market (“Admission”). Admission is expected to occur at 8:00 a.m. on 17 February 2023.

 

Total Voting Rights 

 

Following the issuance of the 243,900 new ordinary shares, the issued share capital of the Company will be 132,215,587 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or changes to their interests in, the Company under the FCA’s Disclosure and Transparency Rules.

For further information, please contact:

The Company

Robert Hewitt (Chief Financial Officer)

Scott Livingston (Chief Executive Officer)

+44 (0) 1932 400 224

AQSE Corporate Adviser and Broker:

VSA Capital Limited

Andrew Raca

Evon Chan

+44 (0) 20 3005 5000

IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Florence Chandler

+44 (0) 20 3934 6630

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END